Ra Capital Management, L.P. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $7.17 Billion distributed in 82 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.45B, Vaxcyte, Inc. with a value of $992M, Janux Therapeutics, Inc. with a value of $416M, Legend Biotech Corp with a value of $366M, and Rhythm Pharmaceuticals, Inc. with a value of $319M.
Examining the 13F form we can see an increase of $536M in the current position value, from $6.64B to 7.17B.
Ra Capital Management, L.P. is based out at Boston, MA
Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.
